News
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...
EMB Portfolio Watchlist EMB Dividend History iShares J.P. Morgan USD Emerging Markets Bond ETF (EMB) Dividend History ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback